The Market Calm Before The Storm?... And Lionsgate’s Nasdaq Debut 5/14/24
CNBC's "Fast Money"
00:00
Personalized Cancer Treatment and Genetic Medicines Opportunities Discussion
Exploring the company's approach to personalized cancer treatment through engineered cells and the potential in genetic medicines like lupus and diabetes. The guest's recognition on the CNBC 50 disruptor list is highlighted, concluding with final trade remarks from other participants.
Play episode from 43:26
Transcript
